ProCE Banner Activity

Initial Systemic Therapy Options for Advanced, Unresectable HCC

Slideset Download
Download this slideset for expert perspectives on the optimal use of systemic therapy in the first-line setting for patients with advanced HCC.

Released: November 10, 2019

Expiration: November 08, 2020

No longer available for credit.

Share

Faculty

Richard S. Finn

Richard S. Finn, MD

Assistant Professor of Medicine
Division of Hematology-Oncology
David Geffen School of Medicine at UCLA
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Bristol Myers Squibb

Eisai

Exelixis

Merck Oncology

Faculty Disclosure

Primary Author

Richard S. Finn, MD

Assistant Professor of Medicine
Division of Hematology-Oncology
David Geffen School of Medicine at UCLA
Los Angeles, California